These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10495327)

  • 1. Comparison of Papnet-assisted and manual screening of cervical smears.
    Losell K; Dejmek A
    Diagn Cytopathol; 1999 Oct; 21(4):296-9. PubMed ID: 10495327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of unsuspected abnormalities by PAPNET-assisted review.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
    Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
    Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
    Hølund B; Ejersbo D; Hjortebjerg A
    Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team.
    Lancet; 1999 Apr; 353(9162):1381-5. PubMed ID: 10227217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of endocervical component by PAPNET system on negative cervical smears.
    Ashfaq R; Solares B; Saboorian MH
    Diagn Cytopathol; 1996 Aug; 15(2):121-3. PubMed ID: 8872433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papnet-assisted, primary screening of cervico-vaginal smears.
    Duggan MA
    Eur J Gynaecol Oncol; 2000; 21(1):35-42. PubMed ID: 10726616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PAPNET-assisted cervical rescreening.
    Doornewaard H; Woudt JM; Strubbe P; van de Seijp H; van den Tweel JG
    Cytopathology; 1997 Oct; 8(5):313-21. PubMed ID: 9313983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of PAPNET system for rescreening of negative cervical smears.
    Ashfaq R; Liang Y; Saboorian MH
    Diagn Cytopathol; 1995 Jul; 13(1):31-6. PubMed ID: 7587873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated cervical cytology: meta-analyses of the performance of the PAPNET system.
    Abulafia O; Sherer DM
    Obstet Gynecol Surv; 1999 Apr; 54(4):253-64. PubMed ID: 10198930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance.
    Ryan MR; Stastny JF; Remmers R; Pedigo MA; Cahill LA; Frable WJ
    Am J Clin Pathol; 1996 Jun; 105(6):711-8. PubMed ID: 8659445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of PAPNET: review of 25,656 Pap smears negative on manual screening and rapid rescreening.
    Halford JA; Wright RG; Ditchmen EJ
    Cytopathology; 1999 Oct; 10(5):317-23. PubMed ID: 10588350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
    van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD
    Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
    Koss LG; Lin E; Schreiber K; Elgert P; Mango L
    Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.